首页> 外文期刊>Therapeutic Drug Monitoring >A diagnostic informatics approach for stratifying risk outcome based on combined genotype effects
【24h】

A diagnostic informatics approach for stratifying risk outcome based on combined genotype effects

机译:基于组合基因型效应的风险信息诊断方法

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Diagnostic informatics (DI) in the context of personalized medicine involves the integration of molecular information to provide "actionable" diagnostic and therapeutic strategies. In many cases, retrospective predictions of clinical outcomes affected by multiple genes are complicated by not having the relevant genes measured within the same study. Multiplicative effect modeling is a statistical method for estimating the net effect of ≥2 independent variables. The authors demonstrate a DI approach that uses multiplicative-effect modeling to combine genetic information from ≥2 independent studies to predict a net clinical outcome. Methods: As a hypothetical working model, 2 independent studies were selected each reporting on a unique genetic factor proposed to influence the risk of stent thrombosis (ST) among subjects treated with clopidogrel. A multiplicative effect model was used for developing a hypothesis regarding their combined influence on clinical outcome. Results: Application of multiplicative risk modeling yielded a revised estimated risk of outcomes based on combined genotype. In this scenario, combined genotype revised the categorical risk level (high versus low) estimated from single gene effects for 41.5% of the subjects. Further, the maximum relative risk based on single gene effects was increased from 4.54 to 7.84 based on combined genotype. The revised relative risk values in conjunction with combined genotype frequency estimates provides the data necessary to frame a trial hypothesis and conduct appropriate power analysis to estimate the number of subjects needed to test that hypothesis. Conclusions: This DI approach can be used to generate quantitative hypotheses on multiple gene effects derived from independent genotype studies. This approach is useful for estimating parameters needed in designing future studies to evaluate the net effect of ≥2 genetic variants on a common clinical endpoint.
机译:背景:个性化医学中的诊断信息学(DI)涉及分子信息的集成,以提供“可行的”诊断和治疗策略。在许多情况下,由于没有在同一研究中测量相关基因,因此受多个基因影响的临床结局的回顾性预测变得复杂。乘法效应建模是一种统计方法,用于估计≥2个独立变量的净效应。作者演示了一种DI方法,该方法使用乘数效应模型来组合来自≥2个独立研究的遗传信息,以预测净临床结果。方法:作为假设的工作模型,选择了2项独立研究,每项研究均报告了一个独特的遗传因素,该遗传因素可影响接受氯吡格雷治疗的受试者的支架血栓形成(ST)的风险。乘数效应模型用于建立关于其对临床结果的综合影响的假设。结果:基于组合基因型,乘法风险模型的应用产生了修订的估计结局风险。在这种情况下,联合基因型修订了从单基因效应评估的41.5%受试者的分类风险水平(高或低)。此外,基于组合基因型,基于单基因效应的最大相对风险从4.54增加到7.84。修订后的相对风险值与基因型频率估计值的组合提供了构成试验假设并进行适当功效分析以估计检验该假设所需的受试者人数所需的数据。结论:该DI方法可用于对来自独立基因型研究的多个基因效应产生定量假设。该方法可用于估计设计未来研究所需的参数,以评估≥2个遗传变异对共同临床终点的净效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号